|
0
Back to Products

GLOWJAROTirzepatide

10 MG · LYOPHILIZED POWDER
In Stock · Ships in 1–3 days
Lab testedBatch reportSealedCold-chain shipping
  • Activates GIP + GLP-1 simultaneously (dual agonist)
  • SURMOUNT-1 study: strong effects on body weight
  • Latest-generation metabolic peptide
  • 1 pen needle always included
  • Batch-matched certificate of analysis
  • Sealed and crimped
  • Ships across the EU
Form
Strength
Certificate of Analysis

Tirzepatide · 10 mg

COA batchGUP-TR10-20260803

Quantity
1
Visa · Mastercard · Amex · SEPAAvailable payment methods are shown at checkout.Shipping & delivery times · Returns & claims
Card & bank transfer
For research purposes only — not intended for human consumption
Product Details
Chemical name
Tirzepatide
Purity
see batch report
CAS Number
2023788-19-2
Molecular formula
C₂₂₅H₃₄₈N₄₈O₆₈
Molecular weight
4.813,45 Da
Mechanism
Dual GIP/GLP-1 receptor agonist
Physical form
Lyophilized powder
Net quantity
10 / 20 / 30 mg per vial
Category
Peptide lyophilizate
Storage
According to label and batch documentation
Light protection
Protect from direct light
Shelf life
According to label and batch documentation
SKU
GUP-TR10
CoA
CoA available
HPLC
Only as stated in a published report
EU
Europe-wide Shipping
Contact
Replies subject to availability

Tirzepatide – Dual GIP/GLP-1 Receptor Agonist

Tirzepatide is a synthetic peptide with agonist activity at both GIP and GLP-1 receptors. This dual receptor activity distinguishes it from selective GLP-1 receptor agonists. GLOWJARO contains lyophilized tirzepatide and is offered exclusively for controlled laboratory research.

Tirzepatide in Research

In preclinical and clinical research – including the SURPASS and SURMOUNT study series – tirzepatide is studied in the context of glucose metabolism, energy balance and receptor signaling pathways. For cell-culture and animal-model studies, precise characterization of purity and identity is essential for reproducible results.

Purity, Analysis & Handling

The Lab Reports page shows whether a report is published for a specifically identified GLOWJARO sample or batch; only the methods and measured results stated there are authoritative. Solvent, reconstitution and storage must suit the material, label and validated laboratory protocol. Background is available in the Tirzepatide article; the laboratory calculator performs mathematical concentration and volume calculations only.

The Tirzepatide Pen – Pre-filled Research Format

Tirzepatide, the dual GIP/GLP-1 receptor agonist, is supplied in the GLOWJARO Pen as a pre-filled research format with a defined concentration. Unlike the vial, it is not intended for reconstitution with bacteriostatic water. The adjustment dial provides repeatable scale values for laboratory workflows; the label and batch-specific documentation remain authoritative.

Laboratory Handling & Dispensing

Before the first laboratory withdrawal, the pen is briefly primed, after which you dial in the desired amount for each laboratory withdrawal. A matching pen needle is always included.

How many clicks do I need?
For this 10 mg pen: 1 mg = 30 clicks on the graduated dial.1 click = 1 unit on the scale. A full pen = 300 clicks (= 10 mg).
AmountClicks on dial
1 mg30
2.5 mg75 (60 + 15)
5 mg150 (60 + 60 + 30)
7.5 mg225 (60 + 60 + 60 + 45)
10 mg300 full pen

The dial turns to a maximum of 60 clicks per setting — set larger amounts in several steps (after the first 60, dial in the remainder again). Work out your exact amount in the pen calculator.

Purity & Quality

A batch-specific analytical report is published for an identified tirzepatide batch; it does not establish testing of unpublished batches. For detailed background on the compound, see the Tirzepatide article; the laboratory calculator is limited to mathematical concentration and volume conversions.

Cart

Your cart is empty

Browse Products